Summary
Elevance Health, Inc. filed an 8-K report on July 17, 2024, to furnish a press release detailing its financial results for the second quarter ended June 30, 2024. The filing primarily serves to inform investors about the company's performance during the quarter, although the specific financial figures are not included in the 8-K text itself but are referenced as being in the furnished press release (Exhibit 99.1). Investors should note that this report, along with the press release, contains forward-looking statements that are subject to various risks and uncertainties. Elevance Health cautions that actual results could differ materially from those projected due to a range of factors, including healthcare cost trends, regulatory changes, operational risks, cyber security threats, competitive pressures, and macroeconomic conditions. The company emphasizes that these forward-looking statements speak only as of the filing date, and they do not undertake to update them.
Key Highlights
- 1Elevance Health (ELV) released its Q2 2024 financial results via an 8-K filing on July 17, 2024.
- 2The filing includes a press release (Exhibit 99.1) containing the detailed quarterly financial results.
- 3The report contains standard forward-looking statements subject to risks and uncertainties.
- 4Investors are cautioned against placing undue reliance on these forward-looking statements.
- 5The company detailed a wide array of potential risks and uncertainties that could impact future performance.
- 6These risks include healthcare cost trends, regulatory environments, cybersecurity, and competitive pressures.